Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cd30 car-t cell (1 trial)
Hodgkin Disease (Phase 2)
Lymphoma (Phase 2)
Lymphoma, T-Cell (Phase 2)
Trials (1 total)
Trial APIs (1 total)